“Efficacy and Safety of Ruxolitinib Plus Extracorporeal Photopheresis in Acute and Chronic Graft Versus Host Disease: A Single Center Experience”. 2021. Annals of Medical Research 28 (11): 2065-70. http://www.annalsmedres.org/index.php/aomr/article/view/3977.